PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

3,5,5-trimethylcyclohex-2-enone

EC / List no: 201-126-0 CAS no: 78-59-1
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Concluded
Decision date
21-Dec-2018
Decision
Latest update
23-Feb-2024
Additional information
More information View
DEv 2
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
DEv 3
Scope
Testing Proposal
Status
Concluded
Decision date
09-Mar-2012
Decision
Latest update
26-Nov-2022
Additional information
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
France
Co-Evaluating Member State
Initial grounds for concern
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Year
2013
Status
Concluded
Conclusion document
Latest update
29-Jun-2022
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
France
Status
Postponed
Outcome
postponed
Hazard assessment outcome document
Remarks
According to the SEv conclusion document, the assessment of the endocrine properties of isophorone should be reviewed at the light of the EOGRTS (final report awaited). This will be analysed in a RMOA.
Concern
Endocrine disruption
Date of intention
13-Sep-2016
Date of hazard assessment
Latest update
26-Jul-2022
More information View
Regulatory risk management
Assessment of regulatory needs
ARN 1
Authority
ECHA
Concern
Status
Under development
Follow-up
Pending action
Foreseen regulatory need
Currently no EU RRM action needed
Summary document
Group name
Unsubstituted and linear aliphatic-substituted cyclic ketones
Remarks
Date of intention
28-Feb-2022
Date of assessment
27-Jun-2022
Latest update
30-Sep-2022
More information View

List entry date: 19-Jan-2016

Export search results to: